284 J . Org. Chem., Vol. 62, No. 2, 1997
Stien et al.
74.1, 76.3, 105.9, 171.7, 172.5. Anal. Calcd for C21H36O6: C,
65.58; H, 9.44. Found: C, 65.54; H, 9.34.
Cycliza tion of 11b. Cyclization of 11b (84 mg, 0.15 mmol)
followed by treatment with catalytic OsO4 and NaIO4 (160 mg,
0.75 mmol) and purification by LC (95/5 hexane/ethyl acetate)
gave 12b and 13b as an inseparable mixture of diastereomers
(44 mg, 60%).
(S*,S*)-4,4-Bis(eth oxyca r bon yl)-5-(4,6-d iisop r op yl-1,3-
d ioxa n -2-yl)-1-p en ten e (10e): 1H NMR (200 MHz) δ 0.83 (d,
J ) 6.6, 3H), 0.86 (d, J ) 6.8, 3H), 0.91 (d, J ) 6.8, 3H), 0.96
(d, J ) 6.6, 3H), 1.23 (t, J ) 7.2, 3H), 1.24 (t, J ) 7.2, 3H),
1.50-1.80 (m, 3H), 2.12-2.36 (m, 3H), 2.62-2.85 (m, 2H), 3.33
(ddd, J ) 11.2, 6.1, 2.9, 1H), 3.47 (ddd, J ) 12.0, 8.8, 1.5, 1H),
4.02-4.25 (m, 4H), 4.81 (dd, J ) 5.9, 3.9, 1H), 5.02-5.16 (m,
2H), 5.61-5.82 (m, 1H). Anal. Calcd for C21H36O6: C, 65.60;
H, 9.44. Found: C, 65.63; H, 9.46.
Cycliza tion of 3f. Cyclization of 3f (166 mg, 0.34 mmol)
gave after treatment with catalytic OsO4 and NaIO4 (364 mg,
1.7 mmol) and purification by LC (95/5 hexane/ethyl acetate)
7f, 8f, and 9f as an inseparable mixture of diastereomers (90
mg, 65%).
Dieth yl 1-Ben zyl-7,9-d i-ter t-bu tyl-6,10-d ioxa sp ir o[4.5]-
d eca n e-3,3-d ica r boxyla te (12b a n d 13b): 1H NMR (300
MHz) δ 0.84 (s, 9H), 0.86 (s, 9H), 0.90 (s, 9H), 0.92 (s, 9H),
1.21 (m, 12H), 1.57 (m, 4H), 2.10 (m, 3H), 2.44 (m, 4H), 2.51
(m, 3H), 2.65 (d, J ) 13.8, 2H), 3.06 (t, J ) 10.0, 2H), 3.44 (m,
4H), 4.14 (m, 8H), 7.14 (m, 6H), 7.28 (m, 4H); 13C NMR (75
MHz) δ 13.8, 13.9, 25.0, 25.2, 25.3, 25.5, 27.3, 27.5, 33.4, 33.9,
34.1, 34.5, 35.2, 35.6, 41.2, 41.9, 48.5, 55.4, 55.8, 61.2, 61.4,
75.1, 75.3, 75.5, 75.8, 108.2, 108.4, 125.6, 128.1, 128.9, 140.9,
141.1, 171.7, 172.2; ν (CH2Cl2) 1731 cm-1
. Anal. Calcd for
C29H44O6: C, 71.28; H, 9.08. Found: C, 71.12; H, 9.11.
(S *,S *)-2-Br om o-4,4-b is(e t h oxyca r b on yl)-5-(4,6-d i-
m et h yl-1,3-d ioxa n -2-yl)-1,1-d ip h en yl-1-p en t en e (14).
Method A. 2-Bromo-4,4-bis(ethoxycarbonyl)-6,6-diethoxy-1,1-
diphenyl-1-hexene (99 mg, 0.18 mmol) and (()-2,4-pentanediol
(23 mg, 0.22 mmol) gave 14 (90 mg, 90%): 1H NMR (300 MHz)
δ 0.87 (d, J ) 7.0, 3H), 1.08 (d, J ) 6.1, 3H), 1.20 (m, 6H),
1.35 (m, 1H), 1.67 (dd, J ) 12.2, 6.1, 1H), 2.28 (dd, J ) 14.5,
3.8, 1H), 2.41 (dd, J ) 14.5, 6.9, 1H), 3.50 (d, J ) 15.3, 1H),
3.52 (m, 1H), 3.82 (d, J ) 15.3, 1H), 4.09 (m, 5H), 4.37 (dd, J
) 6.9, 3.9, 1H), 7.26 (m, 10H); 13C NMR (75 MHz) δ 13.7, 16.4,
21.6, 36.4, 36.6, 39.6, 55.1, 61.3, 61.4, 67.1, 67.8, 90.7, 121.5,
127.3, 127.7, 128.0, 128.3, 128.5, 129.2, 129.7, 140.0, 143.8,
146.4, 170.2, 170.7. Anal. Calcd for C29H35BrO6: C, 62.26;
H, 6.31. Found: C, 62.15; H, 6.22.
Dieth yl 7,9-d i-ter t-bu tyl-1-m eth yl-6,10-d ioxa sp ir o[4.5]-
d eca n e-3,3-d ica r boxyla te (7f, 8f, a n d 9f): 1H NMR (300
MHz) δ 0.82 (s, 9H), 0.85 (s, 9H), 0.93 (d, J ) 6.6, 3H), 1.23
(m, 6H), 1.29 (t, J ) 2.6, 2H), 1.91 (d, J ) 12.5, 1H), 2.07 (m,
2H), 2.38 (dd, J ) 12.8, 7.1, 1H), 3.06 (d, J ) 13.9, 1H), 3.23
(dd, J ) 11.3, 2.3, 1H), 3.34 (dd, J ) 11.3, 2.6, 1H), 4.16 (m,
4H); 13C NMR (75 MHz) δ 11.4, 13.9, 25.1, 25.4, 25.6, 33.8,
34.1, 37.9, 38.0, 43.3, 56.3, 61.2, 61.4, 75.5, 79.0, 105.8, 171.6,
172.8; ν (CH2Cl2) 1731 cm-1
. Anal. Calcd for C23H40O6: C,
66.96; H, 9.77. Found: C, 66.73; H, 9.69.
(S *,S *)-2-Br om o-4,4-b is(e t h oxyca r b on yl)-5-(4,6-d i-
m eth yl-1,3-dioxan -2-yl)-1-ph en yl-1-pen ten e (11a). Method
A. 2-Bromo-4,4-bis(ethoxycarbonyl)-6,6-diethoxy-1-phenyl-1-
hexene (236 mg, 0.5 mmol) and (()-2,4-pentanediol (63 mg,
0.6 mmol) gave 11a (205 mg, 85%) as an inseparable mixture
of E- and Z-isomers: 1H NMR (300 MHz) δ 0.76 (d, J ) 7.6,
3H), 1.03 (d, J ) 6.1, 3H), 1.22 (m, 15H), 1.33 (d, J ) 6.8, 3H),
1.62 (m, 2H), 1.81 (dd, J ) 12.7, 6.2, 2H), 2.18 (dd, J ) 14.4,
3.6, 1H), 2.31 (m, 1H), 2.37 (d, J ) 5.1, 2H), 3.25 (m, 2H), 3.44
(s, 2H), 3.49 (d, J ) 15.5, 1H), 3.76 (d, J ) 15.4, 1H), 3.92 (m,
2H), 4.17 (m, 9H), 5.06 (t, J ) 5.5, 1H), 6.89 (s, 1H), 7.15 (s,
1H), 7.35 (m, 8H), 7.50 (d, J ) 7.3, 2H); 13C NMR (75 MHz) δ
13.7, 13.9, 16.2, 16.9, 21.5, 21.6, 36.2, 36.3, 36.4, 36.6, 37.0,
45.4, 54.5, 54.9, 61.4, 67.1, 67.6, 67.0, 90.5, 91.5, 120.2, 123.9,
127.6, 127.8, 128.0, 128.5, 128.7, 128.8, 133.0,135.7, 136.6,
170.1, 170.3, 170.4. Anal. Calcd for C23H31BrO6: C, 57.15;
H, 6.46. Found: C, 56.99; H, 6.40.
Cycliza tion of 11a . Cyclization of 11a (106 mg, 0.22 mmol)
in 2-methyl-2-propanol (4.4 mL, 0.05 M), followed by treatment
with catalytic OsO4 and NaIO4 (235 mg, 1.1 mmol) and
purification by LC (95/5 hexane/ethyl acetate), gave 12a and
13a as an inseparable mixture of diastereomers (55 mg, 62%).
Diet h yl 1-b en zyl-7,9-d im et h yl-6,10-d ioxa sp ir o[4.5]-
d eca n e-3,3-d ica r boxyla te (12a a n d 13a ): 1H NMR (300
MHz) δ 1.21 (m, 24H), 1.48 (m, 1H), 1.62 (t, J ) 6.9, 4H), 1.99
(m, 1H), 2.13 (d, J ) 13.9, 2H), 2.39 (m, 7H), 2.78 (d, J ) 13.8,
1H), 2.97 (m, 1H), 3.10 (d, J ) 13.8, 1H), 3.99 (m, 3H), 4.14
(m, 9H), 7.22 (m, 10H); 13C NMR (75 MHz) δ 14.0, 21.2, 21.4,
21.7, 21.9, 33.8, 35.1, 37.8, 40.1, 41.0, 41.8, 47.9, 50.0, 56.1,
61.4, 61.5, 61.8, 63.4, 65.3, 66.2, 105.7, 108.5, 125.5, 125.7,
128.1, 128.2, 128.9, 140.7, 141.2, 171.8, 172.3; ν (CH2Cl2) 1726
cm-1. Anal. Calcd for C23H32O6: C, 68.29; H, 7.97. Found:
C, 68.16; H, 7.81.
(S*,S*)-2-Br om o-4,4-bis(eth oxyca r bon yl)-5-(4,6-d i-ter t-
bu tyl-1,3-d ioxa n -2-yl)-1-p h en yl-1-p en ten e (11b). Method
A. 72 (236 mg, 0.5 mmol) and (()-2,2,6,6-tetramethyl-3,5-
heptanediol (113 mg, 0.6 mmol) gave 11b (255 mg, 90%) as
an inseparable mixture of E- and Z-isomers: 1H NMR (300
MHz) δ 0.67 (s, 9H), 0.78 (s, 9H), 0.86 (s, 9H), 0.88 (s, 9H),
1.19 (t, J ) 7.2, 6H), 1.28 (t, J ) 7.3, 6H), 1.62 (t, J ) 5.3,
2H), 2.21 (dd, J ) 4.3, 14.7, 1H), 2.50 (m, 3H), 3.42 (m, 6H),
4.07 (m, 4H), 4.20 (m, 8H), 4.43 (dd, J ) 4.3, 7.6, 1H), 5.05
(dd, J ) 4.0, 7.2, 1H), 6.96 (s, 1H), 7.14 (s, 1H), 7.31 (m, 8H),
7.50 (d, J ) 8.4, 2H); 13C NMR (75 MHz) δ 13.8, 13.9, 22.6,
25.1, 25.4, 25.7, 25.9, 26.7, 26.9, 31.6, 33.5, 33.8, 33.9, 34.1,
35.7, 35.9, 36.8, 41.5, 45.1, 54.7, 54.9, 61.3, 61.6, 62.9, 74.3,
74.8, 79.9, 80.7, 96.0, 97.2, 120.6, 124.2, 127.6, 127.8, 18.0,
128.5, 128.7, 130.0, 135.8, 136.0, 136.6, 169.9, 170.2, 170.3,
170.6; ν (CH2Cl2) 1739 cm-1. Anal. Calcd for C29H43BrO6: C,
61.37; H, 7.64. Found: C, 61.06; H, 7.79.
Cycliza tion of 14. Cyclization of 14 (67 mg, 0.12 mmol)
followed by treatment with catalytic OsO4 and NaIO4 (130 mg,
0.60 mmol) and purification by LC (95/5 hexane/ethyl acetate)
gave 15a and 15b as an inseparable mixture of diastereomers
(32 mg, 62%).
Diet h yl 1-b en zh yd r yl-7,9-d im et h yl-6,10-d ioxa sp ir o-
[4.5]d eca n e-3,3-d ica r boxyla te (15a a n d 15b): 1H NMR (300
MHz) δ 0.81 (d, J ) 6.4, 6H), 0.90 (d, J ) 6.2, 6H), 1.21 (m,
12H), 1.36 (m, 4H), 1.86 (m, 1H), 1.95 (d, J ) 13.7, 1H), 2.17
(d, J ) 14.1, 1H), 2.29 (dd, J ) 13.8, 8.4, 1H), 2.42 (dd, J )
13.7, 7.9, 1H), 2.62 (d, J ) 13.9, 1H), 2.74 (d, J ) 13.9, 1H),
2.90 (m, 1H), 3.05 (d, J ) 14.0, 1H), 3.16 (m, 2H), 3.33 (m,
1H), 3.86 (m, 1H), 4.11 (m, 11H), 7.11 (m, 4H), 7.29 (m, 16H);
13C NMR (75 MHz) δ 14.0, 20.8, 21.1, 21.8, 22.0, 36.3, 37.0,
37.4, 38.2, 42.7, 43.0, 50.6, 51.2, 53.0, 55.4, 56.0, 61.4, 62.4,
63.2, 64.0, 106.2, 107.6, 125.5, 126.0, 127.8, 128.0, 128.1, 128.2,
128.5, 129.0, 144.5, 144.7, 145.1, 171.6, 171.7, 172.2, 172.4.
Anal. Calcd for C29H36O6: C, 72.48; H, 7.54. Found: C, 72.44;
H, 7.32.
(2R*,4a R*,8a R*)-2-[4-Br om o-2,2-bis(et h oxyca r b on yl)-
4-p en t en -1-yl]-4,4,4a -t r im et h ylh exa h yd r ob en zo-1,3-d i-
oxin (23). Method A. The reaction of 1 (255 mg, 0.644 mmol)
with 21 led to 23 as a single epimer (270 mg, 88%), after the
crude product was purified by LC (3% ethyl acetate-pen-
tane): 1H NMR (300 MHz) δ 1.00-1.10 (m, 1H), 1.05 (s, 3H),
1.06 (s, 3H), 1.25 (t, J ) 7.2, 6H), 1.30 (s, 3H), 1.34-1.64 (m,
6H), 1.70-1.78 (m, 1H), 2.34 (d, J ) 5.4, 2H), 3.21 (dd, J )
15.2, 0.7, 1H), 3.30 (dd, J ) 15.2, 0.7, 1H), 3.68 (dd, J ) 11.0,
5.0, 1H), 4.16 (q, J ) 7.2, 2H), 4.16 (q, J ) 7.2, 2H), 5.00 (t, J
) 5.4, 1H), 5.59 (d, J ) 1.5, 1H), 5.74 (m, 1H); 13C NMR (75
MHz) δ 13.5, 13.8, 19.7, 20.8, 24.0, 24.5, 26.7, 30.8, 35.8, 39.2,
43.3, 54.3, 61.2, 76.74, 78.1, 93.2, 122.0, 127.6, 170.1. Anal.
Calcd for C22H35BrO6: C, 55.58; H, 7.42. Found: C, 55.59; H,
7.48.
(2R*,4a R*,8a R*)-2-[4-Br om o-2,2-bis(et h oxyca r b on yl)-
5-ph en yl-4-pen ten -1-yl]-4,4,4a-tr im eth ylh exah ydr oben zo-
1,3-d ioxin (24). Method A. 2-Bromo-4,4-bis(ethoxycarbonyl)-
6,6-diethoxy-1-phenyl-1-hexene (236 mg, 0.5 mmol) and (()-
21 (104 mg, 0.6 mmol) gave 24 (215 mg, 78%) as an inseparable
mixture of E- and Z-isomers: 1H NMR (300 MHz) δ 0.66 (3H,
s), 0.84 (s, 3H), 0.91 (s, 3H), 1.07 (s, 6H), 1.22 (m, 12H), 1.32
(s, 3H), 1.36-1.76 (m, 16H), 2.16 (dd, J ) 14.4, 3.5, 1H), 2.37
(m, 4H),3.45 (m, 4H), 3.70 (dd, J ) 10.9, 4.9, 1H), 3.78 (d, J )
15.5, 1H), 4.00 (m, 1H), 4.14 (m, 8H), 5.06 (t, J ) 5.2, 1H),
6.95 (s, 1H), 7.14 (s, 1H), 7.33 (m, 8H), 7.50 (d, J ) 7.2, 2H);
13C NMR (75 MHz) δ 13.3, 13.6, 13.8, 13.8, 19.2, 19.8, 20.8,